NCT00322569View on ClinicalTrials.gov

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

PHASE3CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

May 31, 2012

Conditions
Coronary Disease
Interventions
DEVICE

Corio™ Pimecrolimus-Eluting Coronary Stent System

Drug-eluting stent

DEVICE

SymBio™ Pimecrolimus/Paclitaxel-Eluting Coronary Stent System

Drug-eluting stent

DEVICE

Costar ™ Paclitaxel-Eluting Coronary Stent System

Drug-eluting Stent

Trial Locations (1)

SO16 YD

Southampton University Hospital, Southampton

Sponsors

Lead Sponsor

Cordis Corporation

Collaborators (1)

Conor Medsystems
All Listed Sponsors
collaborator

Conor Medsystems

INDUSTRY

lead

Cordis Corporation

INDUSTRY

NCT00322569 - A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS) | Biotech Hunter | Biotech Hunter